No abstract

S29 53.46 billion (US$ 8.6 billion). Besides, the intangible cost was estimated in terms of WTP and utility. Patients with MI reported the highest WTP value among the three patient subgroups, while patients with angina reported a higher WTP value than HF patients. Lower utility scores were observed in IHD patients compared to healthy controls. Factors affecting the costs were determined as age, gender, inpatient days, sub-diagnosis type, insurance type, income and utility of patients. CONCLUSIONS: In summary, our study showed ischemic Heart Disease impose heavy economic burden in China. Our study would provide information for making healthcare policy in resource allocation and planning, as well as further clinical research.